Planet 13 Holdings (PLNH) Common Equity (2020 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Common Equity of $43.7 million for Q1 2026, down 60.51% year-over-year from $110.7 million in Q1 2025, and down 14.48% quarter-over-quarter from $51.1 million in Q4 2025.
Planet 13 Holdings (PLNH) Common Equity (2020 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Common Equity for 7 consecutive years, with $43.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 60.51% year-over-year to $43.7 million; the TTM figure through Mar 2026 stood at $43.7 million (down 60.51% YoY), while the FY2025 annual figure was $51.1 million, down 54.64% from the prior year.
- Common Equity slipped to $43.7 million in Q1 2026 per PLNH's latest filing, from $51.1 million in the prior quarter.
- Across five years, Common Equity topped out at $227.8 million in Q1 2022 and bottomed at $43.7 million in Q1 2026.
- Historically, Common Equity has averaged $135.4 million across 5 years, with a median of $120.6 million in 2023.
- Annual changes were most pronounced in 2022 — Common Equity jumped 37.3% — and 2025, when it sank 63.77%.
- Planet 13 Holdings' Common Equity stood at $177.3 million in 2022, then plunged by 39.3% to $107.6 million in 2023, then climbed by 4.71% to $112.7 million in 2024, then sank by 54.64% to $51.1 million in 2025, then declined by 14.48% to $43.7 million in 2026.
- Business Quant data shows PLNH's Common Equity at $43.7 million in Q1 2026, $51.1 million in Q4 2025, and $54.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn | 38.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.80 Mn |
| Mar 31, 2026 | 43.73 Mn |
| Dec 31, 2025 | 51.13 Mn |
| Sep 30, 2025 | 54.58 Mn |
| Jun 30, 2025 | 97.92 Mn |
| Mar 31, 2025 | 110.73 Mn |
| Dec 31, 2024 | 112.71 Mn |
| Sep 30, 2024 | 150.67 Mn |
| Jun 30, 2024 | 158.06 Mn |
| Mar 31, 2024 | 111.74 Mn |
| Dec 31, 2023 | 107.64 Mn |
| Sep 30, 2023 | 120.58 Mn |
| Jun 30, 2023 | 166.23 Mn |
| Mar 31, 2023 | 170.51 Mn |
| Dec 31, 2022 | 177.32 Mn |
| Sep 30, 2022 | 217.40 Mn |
| Jun 30, 2022 | 222.88 Mn |
| Mar 31, 2022 | 227.79 Mn |
| Dec 31, 2021 | 170.71 Mn |
| Sep 30, 2021 | 175.44 Mn |